189 related articles for article (PubMed ID: 31991734)
1. High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection.
Irure-Ventura J; San Segundo D; Rodrigo E; Merino D; Belmar-Vega L; Ruiz San Millán JC; Valero R; Benito A; López-Hoyos M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991734
[TBL] [Abstract][Full Text] [Related]
2. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
[TBL] [Abstract][Full Text] [Related]
3. Serum Soluble B Cell-Activating Factor Is a Non-Invasive Biomarker of Antibody-Mediated Rejection in Kidney Allograft With Satisfactory Risk Stratification Performance But Negligible Diagnostic Value.
Wu S; Su X; Ye Q; Wei Y; Gao Y; Huang M; Chen Y; Wang J; Zhang Q; Fu Q; Li J; Wu C; Huang H; Xu B; Zhang H; Liu L; Wang C
Front Immunol; 2022; 13():869444. PubMed ID: 35493478
[TBL] [Abstract][Full Text] [Related]
4. B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study.
Wang XZ; Wan Z; Xue WJ; Zheng J; Li Y; Ding CG
Front Immunol; 2019; 10():1046. PubMed ID: 31156628
[TBL] [Abstract][Full Text] [Related]
5. Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
Slavcev A; Brozova J; Slatinska J; Sekerkova Z; Honsova E; Skibova J; Striz I; Viklicky O
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):47-53. PubMed ID: 28083608
[TBL] [Abstract][Full Text] [Related]
6. B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation.
Schuster A; Jung B; Hofbauer J; Kühne L; Zecher D; Banas B; Bergler T
Transpl Immunol; 2017 Dec; 45():35-41. PubMed ID: 28867309
[TBL] [Abstract][Full Text] [Related]
7. Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation.
Snanoudj R; Candon S; Roelen DL; Jais JP; Claas FH; Legendre C; Chatenoud L
Transplantation; 2014 May; 97(9):917-24. PubMed ID: 24827764
[TBL] [Abstract][Full Text] [Related]
8. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.
Banham G; Prezzi D; Harford S; Taylor CJ; Hamer R; Higgins R; Bradley JA; Clatworthy MR
Transplantation; 2013 Aug; 96(4):413-20. PubMed ID: 23842189
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
[TBL] [Abstract][Full Text] [Related]
10. B-Cell-Activating Factor Levels Are Associated With Antibody-Mediated Histological Damage in Kidney Transplantation.
Sango C; Merino D; San Segundo D; Rodrigo E; Lopez-Hoyos M; Benito A; Ángeles Ramos M; Gómez-Román J; Arias M
Transplant Proc; 2016 Nov; 48(9):2910-2912. PubMed ID: 27932105
[TBL] [Abstract][Full Text] [Related]
11. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
12. B-cell activating factor BAFF as a novel alert marker for the immunological risk stratification after kidney transplantation.
Schuster AM; Miesgang N; Steines L; Bach C; Banas B; Bergler T
Immunol Res; 2021 Dec; 69(6):487-495. PubMed ID: 34373996
[TBL] [Abstract][Full Text] [Related]
13. B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome.
Xu H; He X; Xu R
J Immunol Res; 2018; 2018():5251801. PubMed ID: 29977928
[TBL] [Abstract][Full Text] [Related]
14. Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.
Noro D; Yoneyama T; Hatakeyama S; Tobisawa Y; Mori K; Hashimoto Y; Koie T; Tanaka M; Nishimura SI; Sasaki H; Saito M; Harada H; Chikaraishi T; Ishida H; Tanabe K; Satoh S; Ohyama C
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28786963
[TBL] [Abstract][Full Text] [Related]
15. B Cell Activating Factor (BAFF) Is Required for the Development of Intra-Renal Tertiary Lymphoid Organs in Experimental Kidney Transplantation in Rats.
Steines L; Poth H; Herrmann M; Schuster A; Banas B; Bergler T
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126753
[TBL] [Abstract][Full Text] [Related]
16. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
[TBL] [Abstract][Full Text] [Related]
17. CD256 can be found in antibody-mediated renal allograft rejection tissues.
Xu H; He X; Zhao W; Guo H; Shi Q; Zhu Y; Zhang X
Clin Lab; 2012; 58(5-6):411-8. PubMed ID: 22783569
[TBL] [Abstract][Full Text] [Related]
18. Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients.
Lanio N; Sarmiento E; Gallego A; Calahorra L; Jaramillo M; Navarro J; Palomo J; Fernandez-Yañez J; Ruiz M; Fernandez-Cruz E; Carbone J
Transpl Int; 2013 Aug; 26(8):800-12. PubMed ID: 23746145
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
[TBL] [Abstract][Full Text] [Related]
20. BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.
Scholzen A; Teirlinck AC; Bijker EM; Roestenberg M; Hermsen CC; Hoffman SL; Sauerwein RW
J Immunol; 2014 Apr; 192(8):3719-29. PubMed ID: 24646735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
